Evidence map›Paper›PMID 42827774›Full record

ReviewFrontiers in immunology2026

Anti-DPPX antibody-associated encephalitis with the first detected anti-Yo antibody during one-year follow-up: a case report.

Ling Yang, Lingling Qiu, Min Zhang, Ting Zeng, Chengyin Wang

Abstract readCase ReportsReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ling Yang *Department of Neurology, The Affiliated Guangzhou Hospital of Traditional Chinese Medicine (TCM) of Guangzhou University of Chinese Medicine, Guangzhou, China.
Lingling Qiu *Department of Neurology, The Affiliated Guangzhou Hospital of Traditional Chinese Medicine (TCM) of Guangzhou University of Chinese Medicine, Guangzhou, China.
Min ZhangDepartment of Neurology, The Affiliated Guangzhou Hospital of Traditional Chinese Medicine (TCM) of Guangzhou University of Chinese Medicine, Guangzhou, China.
Ting ZengDepartment of Neurology, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, China.
Chengyin WangDepartment of Neurology, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-dipeptidyl-peptidase-like protein 6 (DPPX) antibody encephalitis is an ultra-rare subtype of autoimmune encephalitis (AE), with no more than 115 cases reported in the literature to date. Anti-Yo antibody-associated encephalitis is also uncommon. No previous case reports have described anti-DPPX antibody-associated encephalitis with anti-Yo antibody first detected during the one-year follow-up. This article presents the first such case, admitted to the Department of Neurology, the Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University. The patient presented with acute onset manifested by increased muscle tone, neuronal hyperexcitability, autonomic dysfunction and transient myocardial injury. Anti-DPPX antibodies were detected in both serum and cerebrospinal fluid (CSF) upon initial admission, while anti-Yo antibodies were first detected during one-year follow-up. The patient achieved remarkable clinical remission after receiving immunotherapy with intravenous immunoglobulin (IVIG) combined with corticosteroids. We comprehensively summarize the clinical manifestations, diagnostic workup, therapeutic regimen and long-term follow-up outcomes of this case, and conduct a review of the available literature to investigate the pathophysiological mechanisms underlying these two antibodies. This report aims to raise clinicians' awareness of rare subtypes of AE, provide effective treatment strategies, and advance the understanding of the heterogeneous spectrum of AE.

Indexed as

AutoantibodiesAutoantigensEncephalitisNerve Tissue ProteinsDipeptidyl-Peptidases and Tripeptidyl-PeptidasesFollow-Up StudiesHumansImmunoglobulins, IntravenousPotassium ChannelsTreatment OutcomeAutoantibodiesAutoantigensDipeptidyl-Peptidases and Tripeptidyl-PeptidasesDPP6 protein, humanImmunoglobulins, IntravenousNerve Tissue ProteinsPotassium Channelsanti-DPPX antibodyanti-Yo antibodyautoimmune encephalitiscase reportimmunotherapy

Identifiers

PMID42827774
PMCPMC13630750

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.